TransMedics Group Posts Weak Results, Joins Harmonic, Crocs, D.R. Horton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Tuesday.

Shares of TransMedics Group, Inc. TMDX fell in today's pre-market trading following downbeat quarterly results.

TransMedics reported quarterly earnings of 12 cents per share which missed the analyst consensus estimate of 30 cents per share. The company reported quarterly sales of $108.76 million which missed the analyst consensus estimate of $115.00 million.

TransMedics Group shares dipped 25.8% to $93.69 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

• CVR Energy, Inc. CVI shares dipped 25.8% to $17.68 in pre-market trading after the company reported weak quarterly results and said it will not pay cash dividend for the third quarter.
• Xerox Holdings Corporation XRX shares fell 16.4% to $8.59 in pre-market trading after the company reported worse-than-expected third-quarter financial results and cut annual outlook.
• Harmonic Inc. HLIT shares fell 15.8% to $12.48 in pre-market trading after reporting third-quarter results
• Amkor Technology, Inc. AMKR shares declined 11% to $26.27 after the company reported mixed third-quarter financial results.
• Janus International Group, Inc. JBI fell 10.3% to $9.25 in pre-market trading after the company posted downbeat third-quarter results and lowered its sales forecast.
• Crocs, Inc. CROX shares fell 10.3% to $123.80 in pre-market trading following third-quarter results.
• Daqo New Energy Corp. DQ dipped 10.1% to $26.20 in pre-market trading after gaining 14% on Monday.
• D.R. Horton, Inc. DHI shares fell 8% to $165.87 in pre-market trading after the company reported worse-than-expected fourth-quarter EPS and sales.
• Check Point Software Technologies Ltd CHKP fell 6% to $195.40 in pre-market trading following weak quarterly sales.

Now Read This:

• Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone